Results 191 to 200 of about 943,135 (348)
Determining Animal Drug Combinations Based on Efficacy and Safety
D. D. Kratzer, Shu Geng
openalex +1 more source
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song+11 more
wiley +1 more source
Susceptibility of Mycobacterium malmoense to antibacterial drugs and drug combinations
Sven Hoffner+2 more
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
Predicting anticancer synergistic drug combinations based on multi-task learning. [PDF]
Chen D+6 more
europepmc +1 more source
Drug combinations and all cause mortality in heart disease: Dosages and types of ACE inhibitors need to be known [PDF]
Frank A Snyder
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source
AI-driven discovery of synergistic drug combinations against pancreatic cancer. [PDF]
Pourmousa M+18 more
europepmc +1 more source
RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [PDF]
Bertin P+19 more
europepmc +1 more source